Literature DB >> 30305707

21st century glaucoma care.

Harry A Quigley1.   

Abstract

Glaucoma care has evolved dramatically over the past generation, with changes that have incorporated new technology and improved understanding of the disease process. A major need is to construct a useful definition of glaucomatous optic neuropathy that can be used to compare data across clinical research studies. The treatment of glaucoma should now be based on achievement of a goal target for intraocular pressure, unique to each patient. Adherence with eye drop treatment is far from ideal and can be improved using reminder systems. Sustained delivery of glaucoma medication is on the horizon. New surgical approaches to glaucoma are being actively studied but have not as yet found their place in its care, with rigorous testing against present treatments needed.

Entities:  

Mesh:

Year:  2018        PMID: 30305707      PMCID: PMC6367343          DOI: 10.1038/s41433-018-0227-8

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  2 in total

Review 1.  The definition and classification of glaucoma in prevalence surveys.

Authors:  Paul J Foster; Ralf Buhrmann; Harry A Quigley; Gordon J Johnson
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

2.  Epidemiology of glaucoma in Japan--a nationwide glaucoma survey.

Authors:  Y Shiose; Y Kitazawa; S Tsukahara; T Akamatsu; K Mizokami; R Futa; H Katsushima; H Kosaki
Journal:  Jpn J Ophthalmol       Date:  1991       Impact factor: 2.447

  2 in total
  10 in total

1.  Machine Learning-Based Predictive Modeling of Surgical Intervention in Glaucoma Using Systemic Data From Electronic Health Records.

Authors:  Sally L Baxter; Charles Marks; Tsung-Ting Kuo; Lucila Ohno-Machado; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2019-07-16       Impact factor: 5.258

2.  Glucagon-like peptide 1 receptor agonist use is associated with reduced risk for glaucoma.

Authors:  Jacob Sterling; Peiying Hua; Joshua L Dunaief; Qi N Cui; Brian L VanderBeek
Journal:  Br J Ophthalmol       Date:  2021-08-19       Impact factor: 4.638

3.  Smart Electronic Eyedrop Bottle for Unobtrusive Monitoring of Glaucoma Medication Adherence.

Authors:  Marcelo Aguilar-Rivera; Dieanira T Erudaitius; Vincent M Wu; Justin C Tantiongloc; Dae Y Kang; Todd P Coleman; Sally L Baxter; Robert N Weinreb
Journal:  Sensors (Basel)       Date:  2020-04-30       Impact factor: 3.576

Review 4.  What Is New in Glaucoma: From Treatment to Biological Perspectives.

Authors:  Raffaele Nuzzi; Paola Marolo; Alessia Nuzzi
Journal:  J Ophthalmol       Date:  2021-04-14       Impact factor: 1.909

Review 5.  Glucagon-Like Peptide 1 Receptor Agonists - Potential Game Changers in the Treatment of Glaucoma?

Authors:  Zaynab Ahmad Mouhammad; Rupali Vohra; Anna Horwitz; Anna-Sophie Thein; Jens Rovelt; Barbara Cvenkel; Pete A Williams; Augusto Azuara-Blanco; Miriam Kolko
Journal:  Front Neurosci       Date:  2022-02-21       Impact factor: 4.677

6.  Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury.

Authors:  Ling-Ping Cen; Tsz Kin Ng; Jia-Jian Liang; Ciyan Xu; Xi Zhuang; Yu-Fen Liu; Shao-Lang Chen; Yanxuan Xu; Qichen Yang; Xiang-Ling Yuan; Yong Jie Qin; Sun On Chan; Haoyu Chen; Mingzhi Zhang; Andrew V Schally; Chi Pui Pang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

7.  Trends in Surgical Glaucoma Treatment in Germany Between 2006 and 2018.

Authors:  Jan Luebke; Daniel Boehringer; Alexandra Anton; Moritz Daniel; Thomas Reinhard; Stefan Lang
Journal:  Clin Epidemiol       Date:  2021-07-13       Impact factor: 4.790

8.  Endothelin-1 Mediated Decrease in Mitochondrial Gene Expression and Bioenergetics Contribute to Neurodegeneration of Retinal Ganglion Cells.

Authors:  Renuka M Chaphalkar; Dorota L Stankowska; Shaoqing He; Bindu Kodati; Nicole Phillips; Jude Prah; Shaohua Yang; Raghu R Krishnamoorthy
Journal:  Sci Rep       Date:  2020-02-27       Impact factor: 4.996

9.  Success of Primary Trabeculectomy in Advanced Open Angle Glaucoma.

Authors:  Anca Pantalon; Crenguta Feraru; Filip Tarcoveanu; Dorin Chiselita
Journal:  Clin Ophthalmol       Date:  2021-05-27

10.  GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension.

Authors:  Jacob K Sterling; Modupe O Adetunji; Samyuktha Guttha; Albert R Bargoud; Katherine E Uyhazi; Ahmara G Ross; Joshua L Dunaief; Qi N Cui
Journal:  Cell Rep       Date:  2020-11-03       Impact factor: 9.995

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.